Profound Medical Corp Stock Statistic Functions Linear Regression Slope

PROF Stock

USD 5.36 -0.05 -0.92%

Use the statistic functions workspace to apply Linear Regression Slope function and other studies to Profound Medical. The analysis highlights statistical functions describing dispersion and variability and frames technical signals with volatility and risk context.Enter Time Period to execute this module.

Symbol

The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Linear Regression Slope is the rate of change in Profound Medical Corp price series over its benchmark or peer price series.

Profound Medical Technical Analysis Modules

Most technical analysis of Profound Medical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Profound from various momentum indicators to cycle indicators. When you analyze Profound charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

About Profound Medical Corp

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada. Profound Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 146 people. This stock section frames Profound Medical within its peer set and highlights how fundamentals align with price behavior. Current metrics include P/B of 6.13, profit margin of -2.64%. Profound Medical has market cap of 196.34 M, ROE of -67.11%.

Methodology

Unless otherwise specified, financial data for Profound Medical Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Profound (USA Stocks:PROF) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Profound Medical Corp is covered by 5 analysts. 2 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Morgan Stanley, Goldman Sachs, Citigroup, Raymond James, Deutsche Bank, among others. Updates may occur throughout the day.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Profound Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Profound Medical's short interest history, or implied volatility extrapolated from Profound Medical options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.

	Warren Buffett Holdings Invested few shares	Go
	Advertising Invested few shares	Go
	Momentum Invested over 200 shares	Go
	Hedge Favorites Invested over 40 shares	Go
	FinTech Invested over 20 shares	Go
	Video Games Invested few shares	Go
	Impulse Invested over 200 shares	Go
	Macroaxis Picks Invested few shares	Go
	Driverless Cars Invested few shares	Go

More Resources for Profound Stock Analysis

A comprehensive view of Profound Medical Corp starts with financial statements and ratio context. Ratios and trend metrics help frame Profound Medical's operating context. Highlighted below are reports that provide context for Profound Medical Corp Stock:

How To Invest In Profound

Details

Is Profound Stock a good investment?

Details

What is Profound Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Profound Medical has market cap of 196.34 M, operating margin of -123.29%, ROE of -67.11%. See Your Equity Center for portfolio-level analysis. This suggests a position in Profound Medical Corp inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Analysis related to Profound Medical should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Earnings Share

-1.32

Revenue Per Share

0.532

Quarterly Revenue Growth

0.431

Return On Assets

-0.35

Return On Equity

-0.67

Understanding Profound Medical Corp includes distinguishing between market value and book value, where book value reflects Profound accounting equity. Profound Medical's market capitalization is 196.34 M. With a P/B ratio of 6.13, the market values Profound Medical well above its book equity. Enterprise value stands at 174.69 M. Intrinsic value is an estimate of what Profound Medical's fundamentals imply, and it may differ from market and book figures. Analytical frameworks help compare those viewpoints.

The concept of value for Profound Medical differs from its quoted price, since each reflects a different lens. For Profound Medical, key inputs include a P/B ratio of 6.13, a profit margin of -2.64%, ROE of -67.11%, and revenue of 16.1 M. Market price reflects the current exchange level formed by active bids and offers.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Profound Medical Corp Stock Statistic Functions Linear Regression Slope

Profound Medical Technical Analysis Modules

About Profound Medical Corp

Methodology

Analyst Sources

Trending Themes

More Resources for Profound Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY